TECHNOLOGY & PATENTS
Technology Beyond the Lab
We connect research outcomes to patents and commercialization for use in pharmaceutical evaluation and development.

TRANSLATION
From insight
to application.
We extend findings from drug-delivery formulations, luminescent 3D tumoroids, and microfluidic evaluation platforms into intellectual property.
PATENTS & APPLICATIONS
Patent Portfolio

Navigation guidance system for visually impaired persons and control method thereof
- Granted
- 10-29925652026.07.14
- Application
- 10-2024-00312492024.03.05
Patent Details ↗

Automated manufacturing apparatus for nanoparticle-treated drug carriers
- Granted
- 10-29843672026.06.25
- Application
- 10-2024-01913812024.12.19
Patent Details ↗

Microfluidic device for evaluating sustained anticancer activity and the EPR effect of nanoparticle drug formulations
- Granted
- 10-29421372026.03.17
- Application
- 10-2022-00982982022.08.08
- PCT
- PCT/KR2023/0100662023.07.14International Publication WO2024034888A1 · 2024.02.15
Patent Details ↗

TPGS-Soluplus micelles encapsulating olaparib and rapamycin and uses thereof
- Granted
- 10-29139922026.01.13
- Application
- 10-2023-01021942023.08.04
Patent Details ↗

Pneumatically actuated feeding bottle
- Granted
- 10-29111252026.01.07
- Application
- 10-2024-00374562024.03.18
Patent Details ↗

Method for producing luminescent gastric cancer cell-line tumoroids for continuous cytotoxicity analysis of anticancer agents
- Granted
- 10-29104912026.01.06
- Application
- 10-2021-01489702021.11.02
Patent Details ↗

Biometric-data-based medication management system and method
- Application
- 10-2026-01512382026.08.12
Patent Details ↗

Dual-formulation container and aspirin-vitamin C combination drug using the same
- Application
- 10-2026-01346152026.07.22
Patent Details ↗

Microneedle patch for corn removal
- Application
- 10-2026-00539142026.03.25
Patent Details ↗

Bilayer tablet comprising a magnesium salt and a proton-pump inhibitor and method for preparing the same
- Application
- 10-2026-00257492026.02.09
Patent Details ↗

Pharmaceutical composition for preventing or treating macular degeneration comprising thermosensitive PLGA-PEG-PLGA gel encapsulating apatinib or dexamethasone
- Application
- 10-2026-00181042026.01.29
Patent Details ↗

TPGS-Soluplus micelles encapsulating apatinib and etoposide and uses thereof
- Application
- 10-2026-00118932026.01.21
Patent Details ↗

Thermosensitive PLGA-PEG-PLGA hydrogel encapsulating gemcitabine and rapamycin and uses thereof
- Granted
- 10-28859552025.11.10
- Application
- 10-2022-01298072022.10.11
Patent Details ↗

Combination formulation of paclitaxel- and olaparib-loaded TPGS micelles with a pH-thermosensitive hydrogel for peritoneal metastasis and drug-resistant ovarian cancer
- Application
- 10-2024-01861512024.12.13
Patent Details ↗

Poly(ethylene glycol)-poly(caprolactone) copolymer micelles encapsulating sorafenib and uses thereof
- Application
- 10-2024-00897822024.07.08
Patent Details ↗

Polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft-copolymer micelles encapsulating osimertinib, etoposide, and docetaxel and uses thereof
- Application
- 10-2024-00365822024.03.15
Patent Details ↗

Drug evaluation method and system for simulating changes in blood concentration
- Application
- 10-2023-01097442023.08.22
- PCT
- PCT/KR2024/0124992024.08.22International Publication WO2025042211A1 · 2025.02.27
Patent Details ↗

Cut-to-dose tape formulation for pediatric medication
- Application
- 10-2023-00877242023.07.06
Patent Details ↗

Poly(ethylene glycol)-poly(caprolactone) copolymer micelles encapsulating fenbendazole and rapamycin and uses thereof
- Granted
- 10-25846492023.09.26
- Application
- 10-2021-00917112021.07.13
Patent Details ↗

Albumin nanoparticles encapsulating docetaxel and apatinib and uses thereof
- Granted
- 10-25765592023.09.05
- Application
- 10-2021-00768402021.06.14
Patent Details ↗

Poly(ethylene glycol)-poly(caprolactone) copolymer micelles encapsulating docetaxel and osthole and uses thereof
- Granted
- 10-24909402023.01.17
- Application
- 10-2021-00027942021.01.08
Patent Details ↗

pH-sensitive poly(ethylene glycol)-poly(caprolactone) copolymer micelles encapsulating paclitaxel, etoposide, and rapamycin and uses thereof
- Registration
- 10-30201502026.09.10
- Application
- 10-2022-01298082022.10.11
Patent Details ↗

Fenbendazole-solubilizing composition and uses thereof
- Granted
- 10-24554232022.10.12
- Application
- 10-2020-01520442020.11.13
Patent Details ↗

Solubilizing composition for a fingolimod derivative and uses thereof
- Granted
- 10-23773342022.03.17
- Application
- 10-2020-01208772020.09.18
Patent Details ↗

Alpinumisoflavone-solubilizing composition and uses thereof
- Granted
- 10-23007372021.09.06
- Application
- 10-2019-01757152019.12.26
Patent Details ↗

Nanomicelles containing paclitaxel and alpinumisoflavone, preparation method, and uses thereof
- Granted
- 10-22636062021.06.04
- Application
- 10-2020-00163942020.02.11
Patent Details ↗

Disinfecting pen for touching buttons
- Granted
- 10-21852072020.11.25
- Application
- 10-2020-00492002020.04.23
Patent Details ↗

Pharmaceutical composition for preventing or treating glioblastoma comprising gemcitabine-loaded immunoliposomes and bevacizumab
- Granted
- 10-17352842017.05.08
- Application
- 10-2016-00223162016.02.25
Patent Details ↗
KARE · INDUSTRY CONNECTION
